Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$2.77M 44
2022
Q4
$2.77M Hold
25,000
1.43% 22
2022
Q3
$2.15M Sell
25,000
-50,000
-67% -$4.46M 1.26% 25
2022
Q2
$6.84M Sell
75,000
-80,000
-52% -$7.09M 3.96% 10
2022
Q1
$12.7M Buy
155,000
+85,000
+121% +$6.7M 6.02% 4
2021
Q4
$5.37M Buy
+70,000
New +$5.58M 2.21% 18
2020
Q2
Sell
-94,320
Closed -$6.92M 38
2020
Q1
$6.92M Buy
+94,320
New +$7.41M 2.62% 15

Other funds holding MRK

Tamarack Advisers's MRK Position: Q1 2023 in Review

Tamarack Advisers sold out of Merck (MRK) in Q1 2023, closing a stake of 25,000 shares — an estimated $2.77M sold.

Tamarack Advisers first reported a position in MRK in Q1 2020 and held it in 6 quarters. The position peaked at $12.7M in Q1 2022. 3,181 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Tamarack Advisers reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Tamarack Advisers sold 25,000 Merck shares in Q1 2023, an estimated $2.77M.
  • Tamarack Advisers first reported a position in Merck in Q1 2020 and held it in 6 quarters.
  • Tamarack Advisers's Merck position peaked at $12.7M in Q1 2022.
  • 3,181 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Tamarack Advisers's 13F filing for Q1 2023, filed 11 May 2023.